Skip to main content

Table 2 Baseline characteristics of all patients

From: Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases

Characteristic Results
Former or current smoking, n(%) 151 (8.9)
Always drinking, n(%) 107 (6.3)
Comorbidities, n(%)
 Diabetes Mellitus 203 (11.9)
 Hypertension 424 (24.9)
 Dyslipidemia 284 (16.7)
 Hyperuricemia 395 (23.2)
 Hypovitaminosis D 1167 (68.6)
Complications, n(%)
 Femoral head necrosis 28 (1.6)
 Osteoporotic fracture 75 (4.4)
Medication history, yes, n(%)
 Former or current chronic oral Glucocorticoid therapy 713 (41.9)
 NSAIDs 799 (47.0)
 cDMARDs
  1 Type 261 (15.5)
  2 Types 336 (20.0)
  3 Types 124 (7.4)
 bDMARDs 112 (6.6)
Blood calcium level, mean (SD) 2.6 (7.8)
Serum phosphate level, mean (SD) 1.3 (2.6)
Serum creatinine level, median [IQR] 62.0 [53.0, 75.3]
Serum Uric acid level, n(%)
 < 360 1068 (63.6)
 360–419 249 (14.8)
 420 ~ 539 243 (14.5)
 ≥540 118 (7.0)
CRP, median [IQR] 7.1 [1.5, 30.9]
ESR, median [IQR] 34.5 [15.0, 66.0]
Serum 25(OH)D3 level, mean (SD) 64.0 (26.3)
Elevated inflammatory markers, n(%)
 ESR 972 (63.8)
 CRP 729 (47.8)
  1. NSAIDs non-steroidal anti-inflammatory drugs, cDMARDs conventional disease-modifying anti-rheumatic drugs, bDMARDs biological disease-modifying anti-rheumatic drugs, ESR erythrocyte sedimentation rate, CRP c-reactive protein